スポンサーリンク
Division of Immunology, Aichi Cancer Center Research Institute | 論文
- Novel Functions of Herbal Medicines in Dendritic Cells : Role of Amomi Semen in Tumor Immunity
- CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy
- Epstein-Barr virus nuclear antigen 1-specific CD4^+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells
- Aberrant expression of BCL2A1-restricted minor histocompatibility antigens in melanoma cells : application for allogeneic transplantation
- Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions
- Immunity against mouse thymus-leukemia antigen (TL) protects against development of lymphomas induced by a chemical carcinogen, N-butyl-N-nitrosourea
- Thymus-leukemia antigen (TL) as a major histocompatibility complex (MHC) class Ib molecule and tumor-specific antigen
- Thymus leukemia antigen (TL)-specific cytotoxic T lymphocytes recognize the α1/α2 domain of TL free from antigenic peptides
- Comparison of Anti-Tumor Responses against TL Positive Lymphoma Induced by Skin Grafting and Dendritic Cell Immunization
- Murine Delta Homologue, mDelta1, Expressed on Feeder Cells Controls Cellular Differentiation
- The epitope detected by cytotoxic T lymphocytes against thymus leukemia (TL) antigen is TAP independent
- Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1
- Different Susceptibilities of Postmitotic Checkpoint-proficient and-deficient Balb/3T3 Cells to ICRF-193, a Catalytic Inhibitor of DNA Topoisomerase II
- Histiocytic sarcoma of the spleen : case report of asymptomatic onset of thrombocytopenia and complex imaging features
- Recombinant Cholera Toxin B Subunit Activates Dendritic Cells and Enhances Antitumor Immunity
- Age-related EBV-associated B-cell lymphoproliferative disorders : Diagnostic approach to a newly recognized clinicopathological entity
- Mismatched human leukocyte antigen class II-restricted CD8^+ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation
- Glypican-3 could be an effective target for immunotherapy combined with chemotherapy against ovarian clear cell carcinoma